Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
Abramson Cancer Center at Penn Medicine
Study ID
NCT02471170
Status
Enrolling By Invitation

Conditions

  • Pancreatic Diseases

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this study is to collect blood samples to detect potential markers of pancreatic cancer in the blood and link these findings to medical and health information. Information from this study may help to provide insight into the detection of pancreas cancer in the blood before it can be found by other methods or provide a method of monitoring the status of pancreatic cancer throughout a treatment course. Another purpose of this study is to collect blood to create a biobank.

Key Dates

Start date
Sep 10, 2015
Status verified
Apr 2025
Primary completion
Jan 1, 2035
Completion
Jan 1, 2035

Study Design

Enrollment
100 participants (estimated)

Primary Outcome Measure

Collection of blood and tissue samples from subjects with pancreatic diseases [ Time Frame: 3 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Abramson Cancer Center of the University of PennsylvaniaPhiladelphiaPennsylvania19104-

Find similar trials in Philadelphia, PA

By research site
Abramson Cancer Center of the University of Pennsylvania· Philadelphia, PA

Related Studies